Arrowhead Pharmaceuticals Inc (ARWR)
Return on total capital
| Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | — | -580,108 | -188,165 | -178,507 | -140,846 |
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 466,052 | 185,444 | 271,343 | 398,520 | 408,822 |
| Return on total capital | 0.00% | -312.82% | -69.35% | -44.79% | -34.45% |
September 30, 2025 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $466,052K)
= 0.00%